Mylan Invests in EpiPen as Child Allergies Increase

Friday, September 7, 2012 - 20:10 in Health & Medicine

Mylan, the maker of the epinephrine injector EpiPen, is expanding its marketing efforts in the face of new, competing devices and the surging rates of allergies in children.

Read the whole article on NY Times Health

More from NY Times Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net